Jane Street Group LLC purchased a new stake in shares of Calithera Biosciences, Inc. (NASDAQ:CALA) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 15,066 shares of the biotechnology company’s stock, valued at approximately $52,000. Several other hedge funds and other institutional investors have also added to or reduced their...
Read Full StoryRelated
Disease-prevention-and-treatment
US virus numbers drop, but race against new strains heats up; Biden pushes for 1.5M shots per day
, 2min
0
Disease-prevention-and-treatment
Palliative Care Market Insights, Overview, Analysis and Forecast 2021
, 4min
0
Disease-prevention-and-treatment
Vic hits 20 days with no local virus cases, as one Australian Open player slams organisers
, 4min
0